Evidence map›Paper›PMID 40747417›Full record

ArticlebioRxiv : the preprint server for biology2025

A Membrane-Disruptive Action of VBIT-4 Challenges Its Role as a Widely Used VDAC Oligomerization Inhibitor.

Varun Ravishankar, Luís Borges-Araújo, Elodie Lafargue, Deborah Byrne, Nicolas Buzhinsky, Mya S Wolfe, Nina A Bautista, Bethel G Beyene, Motahareh G Larimi, Jean-Pierre Duneau and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Varun RavishankarLaboratoire d'Ingénierie des Systèmes Macromoléculaires, CNRS, UMR 7255 - Aix Marseille Université, 31 Chemin Joseph Aiguier, 13402 Marseille, France.ORCID 0009-0007-6890-6924
Luís Borges-AraújoLaboratoire de Biologie et Modélisation de la Cellule, CNRS, UMR 5239, Inserm, U1293, Université Claude Bernard Lyon 1, Ecole Normale Supérieure de Lyon, Lyon, France.
Elodie LafargueU1325 Aix-Marseille Université, INSERM, DyNaMo, Turing Centre for Living System, Marseille, France.ORCID 0009-0003-1737-9723
Deborah ByrneProtein Expression Facility, Aix Marseille Université, CNRS, IMM, 13402, Marseille, France.
Nicolas BuzhinskyU1325 Aix-Marseille Université, INSERM, DyNaMo, Turing Centre for Living System, Marseille, France.
Mya S WolfeEunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, 20892, USA.
Nina A BautistaEunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, 20892, USA.
Bethel G BeyeneEunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, 20892, USA.
Motahareh G LarimiEunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, 20892, USA.
Jean-Pierre DuneauLaboratoire d'Ingénierie des Systèmes Macromoléculaires, CNRS, UMR 7255 - Aix Marseille Université, 31 Chemin Joseph Aiguier, 13402 Marseille, France.ORCID 0000-0003-4038-5411
James SturgisLaboratoire d'Ingénierie des Systèmes Macromoléculaires, CNRS, UMR 7255 - Aix Marseille Université, 31 Chemin Joseph Aiguier, 13402 Marseille, France.ORCID 0000-0001-5125-7699
Megha RajendranEunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, 20892, USA.ORCID 0000-0001-8078-4738
Sergey M BezrukovEunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, 20892, USA.ORCID 0000-0002-8209-8050
Ignacio CasusoU1325 Aix-Marseille Université, INSERM, DyNaMo, Turing Centre for Living System, Marseille, France.ORCID 0000-0001-7192-0136
Tatiana RostovtsevaEunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, 20892, USA.ORCID 0000-0001-7299-7362
Lucie BergdollLaboratoire d'Ingénierie des Systèmes Macromoléculaires, CNRS, UMR 7255 - Aix Marseille Université, 31 Chemin Joseph Aiguier, 13402 Marseille, France.ORCID 0000-0001-6068-238X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

VDAC, the most abundant protein in the outer mitochondrial membrane, plays a central role in mitochondrial physiology. Its oligomerization has been contemplated to be involved in critical processes such as mtDNA release and apoptosis, yet the underlying molecular mechanisms remain poorly defined. VBIT-4, a small molecule widely used as a VDAC1 oligomerization inhibitor, has seen extensive applications over the past five years without proper mechanistic characterization. Using high-speed atomic force microscopy, we directly visualized VDAC1 oligomerization in planar lipid membranes and examined the effects of VBIT-4. Unexpectedly, VBIT-4 partitioned into lipid bilayers at micromolar concentrations and disrupted membrane structure even in the absence of VDAC1. Complementary approaches-including single-channel electrophysiology, microscale thermophoresis, and coarse-grained molecular dynamics-confirmed the membrane partitioning and destabilizing effects of VBIT-4. The compound also induced VDAC1-independent cytotoxicity in HeLa cells at concentrations above 10 μM. Our findings demonstrate that VBIT-4 disrupts membrane integrity by partitioning into lipids and inducing membrane defects rather than specifically inhibiting VDAC1 oligomerization, highlighting the need for caution when interpreting results and the importance of revisiting conclusions drawn from its prior use.

Indexed as

lipid poresmembrane destabilizationtoxicityVBIT-4VDAC

Identifiers

PMID40747417
PMCPMC12312184

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.